WHO ICTRP trial
Continuous ropivacaine infusion in treatment of postoperative pain in cardiac…
EUCTR2009-017625-20-FI · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-017625-20-FI |
|---|---|
| Public title | Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery. |
| Scientific title | Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery. |
| Primary sponsor | Pawel Florkiewicz |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland |
| Conditions | Research is to verify whether continuous infusion of ropivacaine reduces post-operative analgesic requirement after cardiac surgery. MedDRA version: 12.1 Level: LLT Classification code 10019316 Term: Heart valve disorders MedDRA version… |
| Interventions | Trade Name: Naropin Pharmaceutical Form: INN or Proposed INN: ROPIVACAINE HYDROCHLORIDE CAS Number: 0 Pharmaceutical form of the placebo: Solution for infusion Route of administration of the placebo: Infiltration use |
| Registration date | Mar 5, 2010 |
| Target size | 90 |
| Secondary IDs | NAROSYD |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: